Similarly, Giannoni et al. determined that prostate cancer-derived IL-6 induces the activation and increased expression of FAP by normal human prostate fibroblasts, which, in turn, leads to autocrine-activated fibroblast production of IL-6 and increased prostate cancer cell invasiveness via EMT [36]. Here, IL6 is linked to prostate carcinoma.